Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid. - Wikidata - awgldk - TriplyDB

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

http://www.wikidata.org/entity/Q51904054

about

A therapeutic trial of pro-methylation dietary supplements in Angelman syndrome Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)Developing epigenetic diagnostics and therapeutics for brain disorders Angelman syndrome: A review highlighting musculoskeletal and anatomical aberrations.An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome Angelman Syndrome.Molecular and Clinical Aspects of Angelman Syndrome.Understanding the pathogenesis of Angelman syndrome through animal models Potential therapeutic approaches for Angelman syndrome.Angelman syndrome: review of clinical and molecular aspects.Angelman syndrome: advancing the research frontier of neurodevelopmental disorders.Quantitative Measurement of Communication Ability in Children with Angelman Syndrome.Angelman syndrome: Current and emerging therapies in 2016.Pharmacological therapies for Angelman syndrome.

P2860

Q24594307-60470BB9-B61B-4033-8FB1-42FAF8733C27 Q24610399-247AA0FA-08BF-4476-9452-53A2CB89E5D8 Q24612484-100C41B3-2388-4778-8235-2468FCD300A5 Q26741618-05931BD9-FF5D-4BAC-81A7-4DABD4A03D38 Q27022987-4EA46D97-67F9-4B69-8979-88DE38753305 Q30252074-2080E463-E333-4937-A5F9-626D01EE249E Q34769566-B9C59B9C-D260-4BD9-918E-42E153F45843 Q35811797-935FF9DB-389A-4AA2-A855-378C5FCCB071 Q36006585-83473690-0BFA-4F62-98F5-A08B8540CDFD Q36101992-2ADCB1E1-50CD-42E4-BFBC-71F0CB5C4AEA Q36992786-7FB499A4-46C8-4605-86B8-C5D76F98F5EA Q38216017-A6F5C203-1D71-4B1F-865B-028406A8648B Q38271962-122E0F42-8ADC-477F-A6FC-147EDA187F57 Q38781012-E4E91A54-A229-4C68-B053-DBC099F53A52 Q39012491-05FDE5F9-9DE1-4015-8956-9B0BFFE742A7 Q46368852-F4038896-699E-45D6-885F-F214E0A06DB1

P2860

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

http://www.wikidata.org/entity/Q51904054

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

@en

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

@nl

type

label

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

@en

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

@nl

prefLabel

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

@en

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

@nl

P1433

Q51904054-79D07F05-E9F8-404E-88F8-34E8EDCF20EF

P1476

Q51904054-1A9BB497-5816-4FFF-9921-C61FD9B05769

P2093

Q51904054-1B039EE3-4AB0-48AA-9CBA-59E350E40705

Q51904054-380B1DF7-C58A-4A54-BDD3-BB97303382EA

Q51904054-3ED521E6-DC4C-48C9-AB44-B4A63A55F9E2

Q51904054-43441AE6-5825-4E1B-B877-11DE4E5AE391

Q51904054-55B33499-A177-44EC-8615-565B6E007E6A

Q51904054-5AE7055B-FFB5-45FB-B035-1B97F5BD8B08

Q51904054-6706BEC5-074F-4F5A-937F-77F0EDB297EF

Q51904054-7622611C-2EA9-45D8-A662-22E31843DB28

Q51904054-77822D55-B251-4265-BC8A-5146B44194AD

Q51904054-99642E1B-5201-4598-BDDC-C20758CE2A1F

P2860

Q51904054-0737B9D1-3A89-4AFC-8F1D-6E2F612578A1

Q51904054-0DC418D2-FCAF-40F9-B32A-3783F0FE12B2

Q51904054-126AC643-F044-440D-8628-640AED053663

Q51904054-1913FED4-CCA2-486C-A7C5-104AED188B3D

Q51904054-2245AB0D-EB3F-4DBE-974E-05D7A6C234E4

Q51904054-286F05C5-8351-4C1F-A8DB-5DD4FE73FCBA

Q51904054-2B932634-C6FC-462F-A0D4-0F4C4F965F03

Q51904054-344C37DA-6EDA-46CF-8496-408E4F2CAC7D

Q51904054-3845E21F-FEF5-4D04-AC71-42A19AEA1D16

Q51904054-392695A9-71F4-4123-AE10-5FDBF6EEA6FF

P304

Q51904054-CE175E4E-4CA7-4CFA-91AD-0F73AFE822A9

P31

Q51904054-96C8B6E5-4291-4937-A711-457B92358F4F

P356

Q51904054-965A2400-983D-45D0-A431-B48DF3B6A869

P407

Q51904054-F7B276A3-A561-4B00-9FCA-F3FBFA5DE308

P433

Q51904054-226116E0-CC46-4B2C-8914-2F9FE07D2B02

P478

Q51904054-B7711DC5-ACAC-4481-99E5-DAA29E763BF3

P50

Q51904054-36B47A9D-875B-4DFC-99AF-AE2262FC9C49

Q51904054-AC4D3319-2959-4252-9DC6-2A8531CBC3DD

Q51904054-E46B3087-7679-418F-8079-E7F4219E4EBD

P577

Q51904054-D2AE801A-36CB-4366-90F3-45BA4F679F49

P5875

Q51904054-04ED0E4F-EB66-4805-B7B3-C6A4CB64EF71

P698

Q51904054-65D9D647-CCD4-4939-B14D-FC972A49A069

P932

Q51904054-6036368B-451A-4975-8BE8-33F16F179895

P356

P1433

American Journal of Medical Genetics

P1476

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid

@en

P2093

Arthur L Beaudet

http://www.w3.org/2001/XMLSchema#string

Carlos A Bacino

http://www.w3.org/2001/XMLSchema#string

Daniel G Glaze

http://www.w3.org/2001/XMLSchema#string

Erica Sanborn

http://www.w3.org/2001/XMLSchema#string

Irina Anselm

http://www.w3.org/2001/XMLSchema#string

Lina M Shinawi

http://www.w3.org/2001/XMLSchema#string

Mark Nespeca

http://www.w3.org/2001/XMLSchema#string

Rene Barbieri-Welge

http://www.w3.org/2001/XMLSchema#string

Sarika U Peters

http://www.w3.org/2001/XMLSchema#string

Susan Waisbren

http://www.w3.org/2001/XMLSchema#string

P2860

UBE3A/E6-AP mutations cause Angelman syndrome

The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A

A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A

Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate

Genetics of Angelman syndrome.

Autism in Angelman syndrome: a population-based study.

Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring.

The Angelman ("happy puppet") syndrome.

Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation.

Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis

P304

1994-2001

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJMG.A.33509

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

152A

http://www.w3.org/2001/XMLSchema#string

P50

Terry Jo V Bichell

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45200925

http://www.w3.org/2001/XMLSchema#string

P698

20635355

http://www.w3.org/2001/XMLSchema#string

P932

3172130

http://www.w3.org/2001/XMLSchema#string